Buoy Health Strategic Partnerships Expand Digital Corporate Benefits Program Options February 13, 2019
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of an Anti-OX40 Antibody February 13, 2019
Orchard Therapeutics Announces Acceptance of Late-Breaking Abstracts of OTL-101 for ADA-SCID and OTL-102 for X-CGD at the 2019 Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR February 6, 2019
Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388 February 4, 2019
Hua Medicine Initiates First Combination Study of Dorzagliatin with a DPP-4 Inhibitor in the United States February 1, 2019
VitalWare™ Achieves #1 in KLAS Revenue Cycle – Chargemaster Management Category for 2019 January 31, 2019
Menlo Therapeutics Announces Late-Breaking Oral Presentation at the American Academy of Dermatology Annual Meeting January 30, 2019